Rob Hastings

Rob Hastings

Company: AstraZeneca

Job title: Precision Medicine Portfolio Lead, Cardiovascular, Renal & Metabolism


Rob Hastings is Precision Medicine Portfolio Lead in Cardiovascular, Renal and Metabolism at AstraZeneca.

Rob is a physician and completed his medical degree, general adult, and specialist training in Clinical Genetics in Bristol. He has a clinical and research interest in inherited cardiovascular conditions. He has a DPhil in Cardiovascular Medicine from the University of Oxford and is an Honorary Consultant at Addenbrooke’s Hospital, Cambridge.

As well as the NHS he has previously worked as a health and life science strategy consultant at Monitor Deloitte; at Genomics England setting up the genomic medicine centres for the 100,000 Genomes Project; developing population sequencing projects across Europe and the Middle East at Illumina; supporting diagnostics development and adaptive trials support for SMEs in the UK at the Precision Medicine Catapult; and as an independent consultant wrote the initial proposal for the Million European Genome Alliance (MEGA) project that has been ratified across 15 European member states to support genomics research collaboration.


Precision Medicine Outside Oncology: Where Are We Now & Where Are We Going? 3:45 pm

The current position of precision medicine within pharma development. Describing different approaches to patient selection and trial design with internal and external examples. Highlight examples of where companion diagnostics are being developed as a classical precision medicine approach Diagnostics to support clinical trials and non-precision medicines as a path to increasing knowledge and interest internally…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.